公开(公告)号：AU2016351308A1

公开(公告)日：2018-04-26

申请号：AU2016351308

申请日：2016-11-04

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: A61K38/18 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C07K14/495 ,  C08B37/08

Abstract: Compositions comprising combinations of chondroitin, glucosamine, connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGFβ1) and WISP-2 are disclosed. Methods, uses and systems relating to the reduction of pain in a patient that emanates from a body area, preferably spine or joint are described. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

公开(公告)号：NZ741320A

公开(公告)日：2019-12-20

申请号：NZ74132016

申请日：2016-11-04

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: A61K38/18 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C07K14/495 ,  C08B37/08

Abstract: Compositions comprising combinations of chondroitin, glucosamine, connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGFβ1) and WISP-2 are disclosed. Methods, uses and systems relating to the reduction of pain in a patient that emanates from a body area, preferably spine or joint are described. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

公开(公告)号：PE20181294A1

公开(公告)日：2018-08-07

申请号：PE2018000735

申请日：2016-11-04

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: A61K38/18 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C07K14/495 ,  C08B37/08

Abstract: Se refiere a una composicion que comprende sulfato de condroitina de 0.1% a 2 % en peso, clorhidrato de glucosamina de 1% a 25% en peso, factor de crecimiento de tejido conjuntivo de 50 ng/mg a 500 ng/mg, factor de crecimiento transformante beta 1 de 10 ng/mg a 100ng/mg y una solucion acuosa que comprende agua, solucion amortiguadora y/o sulfoxido de dimetilo. Dicha composicion es util en el tratamiento o prevencion de una enfermedad discal degenerativa, lesion de disco, dolor, entre otras

公开(公告)号：AU2021232825B2

公开(公告)日：2025-03-27

申请号：AU2021232825

申请日：2021-09-17

Applicant: NOTOGEN INC ,  UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK ,  EEK BJORN C J

IPC: C07K14/495 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61K38/18 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C08B37/08

Abstract: Compositions comprising combinations of chondroitin, glucosamine, connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGFp1) and WISP-2 are disclosed. Methods, uses and systems relating to the reduction of pain in a patient that emanates from a body area, preferably spine orjoint are described. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

公开(公告)号：AU2019250267B2

公开(公告)日：2021-06-17

申请号：AU2019250267

申请日：2019-10-18

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: C07K14/495 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61K38/18 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C08B37/08

Abstract: Compositions comprising combinations of chondroitin, glucosamine, connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGFp1) and WISP-2 are discosed. Methods, uses and systems relating to the reduction of pain in a patient that emanates from a body area, preferably spine orjoint are described. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

公开(公告)号：AU2019250267A1

公开(公告)日：2019-11-07

申请号：AU2019250267

申请日：2019-10-18

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: C07K14/495 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61K38/18 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C08B37/08

Abstract: Compositions comprising combinations of chondroitin, glucosamine, connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGFp1) and WISP-2 are discosed. Methods, uses and systems relating to the reduction of pain in a patient that emanates from a body area, preferably spine orjoint are described. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

公开(公告)号：AU2016351308B2

公开(公告)日：2019-10-17

申请号：AU2016351308

申请日：2016-11-04

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: C07K14/495 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61K38/18 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C08B37/08

Abstract: Compositions comprising combinations of chondroitin, glucosamine, connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGFβ1) and WISP-2 are disclosed. Methods, uses and systems relating to the reduction of pain in a patient that emanates from a body area, preferably spine or joint are described. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

公开(公告)号：AU2019250267C1

公开(公告)日：2022-01-06

申请号：AU2019250267

申请日：2019-10-18

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: C07K14/495 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61K38/18 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C08B37/08

Abstract: Compositions comprising combinations of chondroitin, glucosamine, connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGFp1) and WISP-2 are discosed. Methods, uses and systems relating to the reduction of pain in a patient that emanates from a body area, preferably spine orjoint are described. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

公开(公告)号：AU2021232825A1

公开(公告)日：2021-10-14

申请号：AU2021232825

申请日：2021-09-17

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: C07K14/495 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61K38/18 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C08B37/08

Abstract: Compositions comprising combinations of chondroitin, glucosamine, connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGFp1) and WISP-2 are disclosed. Methods, uses and systems relating to the reduction of pain in a patient that emanates from a body area, preferably spine orjoint are described. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

公开(公告)号：AU2019250267B9

公开(公告)日：2021-07-08

申请号：AU2019250267

申请日：2019-10-18

Applicant: UNIV HEALTH NETWORK

Inventor： ERWIN WILLIAM MARK

IPC: C07K14/495 ,  A61K9/08 ,  A61K31/7008 ,  A61K31/737 ,  A61K38/18 ,  A61P19/00 ,  A61P19/02 ,  C07H5/06 ,  C07K14/475 ,  C08B37/08

Abstract: Compositions comprising combinations of chondroitin, glucosamine, connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGFp1) and WISP-2 are discosed. Methods, uses and systems relating to the reduction of pain in a patient that emanates from a body area, preferably spine orjoint are described. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.